Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

This publication has 28 references indexed in Scilit:

• High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin’s disease is unlikely to be associated with a major increased risk of secondary MDS/AML
  British Journal of Cancer, 1999
• Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT
  British Journal of Haematology, 1999
• Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1999
• Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma
  British Journal of Haematology, 1996
• Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
  Journal of Clinical Oncology, 1994
• Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation.
  Journal of Clinical Oncology, 1994
• Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.
  Journal of Clinical Oncology, 1990
• High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1987
• National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
  Cancer, 1982
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958